BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21566107)

  • 1. Dialyzer reuse with peracetic acid does not impact patient mortality.
    Bond TC; Nissenson AR; Krishnan M; Wilson SM; Mayne T
    Clin J Am Soc Nephrol; 2011 Jun; 6(6):1368-74. PubMed ID: 21566107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abandoning peracetic acid-based dialyzer reuse is associated with improved survival.
    Lacson E; Wang W; Mooney A; Ofsthun N; Lazarus JM; Hakim RM
    Clin J Am Soc Nephrol; 2011 Feb; 6(2):297-302. PubMed ID: 20947788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dialyzer reuse on survival of patients treated with hemodialysis.
    Feldman HI; Kinosian M; Bilker WB; Simmons C; Holmes JH; Pauly MV; Escarce JJ
    JAMA; 1996 Aug; 276(8):620-5. PubMed ID: 8773634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the association of dialyzer reuse practices and patient outcomes.
    Held PJ; Wolfe RA; Gaylin DS; Port FK; Levin NW; Turenne MN
    Am J Kidney Dis; 1994 May; 23(5):692-708. PubMed ID: 8172212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National Kidney Foundation report on dialyzer reuse. Task Force on Reuse of Dialyzers, Council on Dialysis, National Kidney Foundation.
    Am J Kidney Dis; 1997 Dec; 30(6):859-71. PubMed ID: 9398135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of bleach cleaning on the performance of dialyzers with polysulfone membranes processed for reuse using peracetic Acid.
    Ward RA; Ouseph R
    Artif Organs; 2003 Nov; 27(11):1029-34. PubMed ID: 14616521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dialyzer reprocessing with peroxyacetic acid as sole cleansing and sterilizing agent.
    Kes P; Reiner Z; Ratković-Gusić I
    Acta Med Croatica; 1997; 51(2):87-93. PubMed ID: 9204593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dialyzer reuse--part II: advantages and disadvantages.
    Twardowski ZJ
    Semin Dial; 2006; 19(3):217-26. PubMed ID: 16689973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of dialyzer reuse on dialysis delivery.
    Sherman RA; Cody RP; Rogers ME; Solanchick JC
    Am J Kidney Dis; 1994 Dec; 24(6):924-6. PubMed ID: 7985670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics: results from the usrds dialysis morbidity and mortality study.
    Port FK; Wolfe RA; Hulbert-Shearon TE; Daugirdas JT; Agodoa LY; Jones C; Orzol SM; Held PJ
    Am J Kidney Dis; 2001 Feb; 37(2):276-86. PubMed ID: 11157367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FMCNA says data shows higher risk of mortality among patients on reuse. Industry questions bias in reporting.
    Neumann ME
    Nephrol News Issues; 2004 Oct; 18(11):91. PubMed ID: 15551620
    [No Abstract]   [Full Text] [Related]  

  • 12. Reuse and Biocompatibility of Hemodialysis Membranes: Clinically Relevant?
    Upadhyay A; Jaber BL
    Semin Dial; 2017 Mar; 30(2):121-124. PubMed ID: 28066932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dialyzer reuse-Part I: Historical perspective.
    Twardowski ZJ
    Semin Dial; 2006; 19(1):41-53. PubMed ID: 16423181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A quality and cost-benefit analysis of dialyzer reuse in hemodialysis patients.
    Chuang FR; Lee CH; Chang HW; Lee CN; Chen TC; Chuang CH; Chiou TT; Wu CH; Yang CC; Wang IK
    Ren Fail; 2008; 30(5):521-6. PubMed ID: 18569933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of dialyzer reuse and hospitalization rates among hemodialysis patients in the US.
    Feldman HI; Bilker WB; Hackett M; Simmons CW; Holmes JH; Pauly MV; Escarce JJ
    Am J Nephrol; 1999; 19(6):641-8. PubMed ID: 10592357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and treatment of patients not reusing dialyzers in reuse units.
    Okechukwu CN; Orzol SM; Held PJ; Pereira BJ; Agodoa LY; Wolfe RA; Port FK
    Am J Kidney Dis; 2000 Nov; 36(5):991-9. PubMed ID: 11054356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biocompatibility and permeability of dialyzer membranes do not affect anemia, erythropoietin dosage or mortality in japanese patients on chronic non-reuse hemodialysis: a prospective cohort study from the J-DOPPS II study.
    Yokoyama H; Kawaguchi T; Wada T; Takahashi Y; Higashi T; Yamazaki S; Fukuhara S; Akiba T; Akizawa T; Asano Y; Kurokawa K; Saito A;
    Nephron Clin Pract; 2008; 109(2):c100-8. PubMed ID: 18596379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of hemodialyzer reuse on clearances of urea and beta2-microglobulin. The Hemodialysis (HEMO) Study Group.
    Cheung AK; Agodoa LY; Daugirdas JT; Depner TA; Gotch FA; Greene T; Levin NW; Leypoldt JK
    J Am Soc Nephrol; 1999 Jan; 10(1):117-27. PubMed ID: 9890317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dialyzer reuse and mortality risk in patients with end-stage renal disease: a systematic review.
    Galvao TF; Silva MT; Araujo ME; Bulbol WS; Cardoso AL
    Am J Nephrol; 2012; 35(3):249-58. PubMed ID: 22353780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintaining blood compartment volume in dialyzers reprocessed with peracetic acid maintains Kt/V but not beta2-microglobulin removal.
    Ouseph R; Smith BP; Ward RA
    Am J Kidney Dis; 1997 Oct; 30(4):501-6. PubMed ID: 9328364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.